We Collected Blood Samples From Septic Shock Patients and Measured ELABELA, Creatinine, and NGAL Levels. Survival After 7 Days Was Recorded and Analyzed to Evaluate the Potential of Serum ELABELA as an Early Diagnostic Marker for Sepsis-associated Acute Kidney Injury.

NCT06001294 · clinicaltrials.gov ↗
UNKNOWN
Status
70
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Xiangcheng Zhang